ArticleProtein & cell2011

Parkinson disease drug screening based on the interaction between D(2) dopamine receptor and beta-arrestin 2 detected by capillary zone electrophoresis.

Zheng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.